We are live on ! Find out more
AC

Aristeia Capital Portfolio holdings

AUM $4.82B
1-Year Est. Return 24.94%
This Fund
S&P 500
This Quarter Est. Return
+6.07%
1 Year Est. Return
+24.94%
3 Year Est. Return
+78.83%
5 Year Est. Return
+102.49%
10 Year Est. Return
+757.46%
AUM
$1.51B
AUM Growth
-$207M
Cap. Flow
-$1.07B
Cap. Flow %
-70.43%
Top 10 Hldgs %
79%
Holding
78
New
16
Increased
7
Reduced
6
Closed
24

Sector Composition

Rank Sector Weight
1 Communication Services 25.81%
2 Financials 0.61%
3 Energy 0.53%
4 Consumer Discretionary 0.5%
5 Healthcare 0.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NIO icon
26
NIO
NIO
$11.3B
$991K 0.07%
246,600
MDR
27
DELISTED
McDermott International
MDR
$811K 0.05%
1,198,424
-566,808
-32% -$724K
CHK
28
DELISTED
Chesapeake Energy Corporation
CHK
$619K 0.04%
+3,750
New +$754K
SPCE.WS
29
DELISTED
Virgin Galactic Holdings, Inc. Warrants, each whole warrant exercisable for one share of Common Stoc
SPCE.WS
$452K 0.03%
+135,038
New +$324K
NEBUW
30
DELISTED
Nebula Acquisition Corporation Warrant
NEBUW
$359K 0.02%
+276,341
New +$275K
ECOLW
31
DELISTED
US Ecology, Inc. Warrant
ECOLW
$134K 0.01%
+11,524
New +$116K
PACQW
32
DELISTED
Pure Acquisition Corp. Warrant
PACQW
$123K 0.01%
+125,050
New +$134K
MOSC.WS
33
DELISTED
Mosaic Acquisition Corp. Warrants, each exercisable for one Class A Common Stock at an exercise pric
MOSC.WS
$72K ﹤0.01%
74,181
-96,419
-57% -$82.6K
KLR.WS
34
DELISTED
Kaleyra, Inc. Warrants, each whole Warrant exercisable for one share of Common Stock at an exercise price of $40.25 per share
KLR.WS
$57K ﹤0.01%
+50,000
New +$45K
AHCO icon
35
AdaptHealth
AHCO
$1.46B
-1,319,551
Closed -$13.4M
ANGI icon
36
Angi Inc
ANGI
$224M
-167,774
Closed -$11.9M
APLS
37
DELISTED
Apellis Pharmaceuticals
APLS
-11,600
Closed -$279K
CSTM icon
38
Constellium
CSTM
$3.96B
-199,695
Closed -$2.54M
ETSY icon
39
Etsy
ETSY
$7.65B
-88,800
Closed -$5.02M
GLD icon
40
CALL
SPDR Gold Trust
GLD
$131B
-325,000
Closed -$45.1M
IQ icon
41
iQIYI
IQ
$1.18B
-66,000
Closed -$1.06M
OKTA icon
42
Okta
OKTA
$24.1B
-11,273
Closed -$1.11M
RH icon
43
RH
RH
$3.3B
-3,200
Closed -$547K
SPCE icon
44
Virgin Galactic
SPCE
$320M
-610
Closed -$130K
XLF icon
45
State Street Financial Select Sector SPDR ETF
XLF
$55.6B
-228,622
Closed -$6.4M
BEST
46
DELISTED
BEST Inc. American Depositary Shares, each representing twenty (20) Class A Ordinary Shares
BEST
-11,325
Closed -$1.2M
AERI
47
DELISTED
Aerie Pharmaceuticals
AERI
-151,350
Closed -$2.91M
SAIL
48
DELISTED
SailPoint Technologies Holdings, Inc. Common Stock
SAIL
-63,400
Closed -$1.19M
PFPT
49
DELISTED
Proofpoint, Inc.
PFPT
-9,527
Closed -$1.23M
PACQU
50
DELISTED
Pure Acquisition Corp. Unit
PACQU
-250,100
Closed -$2.68M

Similar funds

Aristeia Capital's Q4 2019 Portfolio in Review

As of Q4 2019, Aristeia Capital held 78 positions worth $1.51B, down 12% from $1.72B the previous quarter. Its ten largest holdings account for 79% of the portfolio.

Aristeia Capital withdrew a net $1.07B in Q4 2019, closing 24 positions and reducing 6 holdings. Its most notable exit was Altaba Inc, an estimated $317M position sold in full.

By sector, the portfolio is most concentrated in Communication Services at 26% of assets, up from 19% a quarter earlier, followed by Financials and Energy.

Against the trend, Aristeia Capital opened a new position in Bristol-Myers Squibb Company Contingent Value Rights worth $16.8M.

  • Aristeia Capital's largest Q4 2019 buy was Bristol-Myers Squibb Company Contingent Value Rights: 5,591,743 shares worth $16.8M.
  • Aristeia Capital added most to People Inc in Q4 2019, an estimated $159M increase.
  • Aristeia Capital's biggest Q4 2019 reduction was Match Group, cutting an estimated $129M.
  • Aristeia Capital fully exited Altaba Inc in Q4 2019, selling an estimated $317M.
  • Aristeia Capital's ten largest holdings make up 79% of its $1.51B portfolio in Q4 2019.
  • Aristeia Capital opened 16 new positions and closed 24 in Q4 2019.
  • Aristeia Capital's portfolio value fell 12% quarter-over-quarter to $1.51B.

Based on Aristeia Capital's 13F filing for Q4 2019, filed 18 Feb 2020.